Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3692 | 1930 | 49.1 | 91% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
332 | 3 | ERYTHROPOIETIN//ANEMIA//FERRITIN | 37752 |
388 | 2 | ERYTHROPOIETIN//ANEMIA//IRON DEFICIENCY | 16969 |
3692 | 1 | ERYTHROPOIETIN//CELLULAR MOL CEREBRAL I EMIA//CARBAMYLATED ERYTHROPOIETIN | 1930 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ERYTHROPOIETIN | authKW | 2769616 | 50% | 18% | 965 |
2 | CELLULAR MOL CEREBRAL I EMIA | address | 634795 | 3% | 76% | 53 |
3 | CARBAMYLATED ERYTHROPOIETIN | authKW | 325426 | 1% | 86% | 24 |
4 | ERYTHROPOIETIN RECEPTOR | authKW | 300654 | 4% | 24% | 78 |
5 | EPO | authKW | 209104 | 4% | 19% | 69 |
6 | ASIALOERYTHROPOIETIN | authKW | 159513 | 1% | 92% | 11 |
7 | EPO RECEPTOR | authKW | 86228 | 1% | 42% | 13 |
8 | RHEPO | authKW | 71411 | 1% | 27% | 17 |
9 | ERYTHROPOIETIN EPO | authKW | 71150 | 1% | 19% | 24 |
10 | ARA290 | authKW | 65914 | 0% | 83% | 5 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Neurosciences | 2676 | 23% | 0% | 450 |
2 | Medicine, Research & Experimental | 990 | 9% | 0% | 183 |
3 | Clinical Neurology | 838 | 10% | 0% | 202 |
4 | Cardiac & Cardiovascular System | 589 | 8% | 0% | 156 |
5 | Critical Care Medicine | 481 | 3% | 0% | 66 |
6 | Urology & Nephrology | 461 | 5% | 0% | 101 |
7 | Pharmacology & Pharmacy | 404 | 11% | 0% | 211 |
8 | Hematology | 391 | 5% | 0% | 99 |
9 | Cell Biology | 366 | 9% | 0% | 174 |
10 | Peripheral Vascular Diseases | 345 | 5% | 0% | 90 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CELLULAR MOL CEREBRAL I EMIA | 634795 | 3% | 76% | 53 |
2 | CELLULAR MOL SIGNALING | 58235 | 0% | 41% | 9 |
3 | MOL MED GENET ENVIRONM HLTH SCI | 56496 | 0% | 71% | 5 |
4 | MOL MED BRANCH | 48779 | 1% | 16% | 19 |
5 | SECT EXPT NEUROSURG | 42183 | 0% | 67% | 4 |
6 | ENVIRONM HLTH SCI MOL MED GENET | 35593 | 0% | 75% | 3 |
7 | CARDIOVASC GENE THER Y UNIT | 31639 | 0% | 100% | 2 |
8 | MOL CELL BIOL BRANCH | 31639 | 0% | 100% | 2 |
9 | MOL MED GENET NEUROL | 31639 | 0% | 100% | 2 |
10 | NEONATOLJHMHC | 31639 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CURRENT NEUROVASCULAR RESEARCH | 27663 | 2% | 6% | 29 |
2 | MOLECULAR MEDICINE | 4909 | 1% | 1% | 22 |
3 | CARDIOVASCULAR DRUGS AND THERAPY | 1576 | 1% | 1% | 14 |
4 | NEONATOLOGY | 1032 | 0% | 1% | 8 |
5 | PEDIATRIC RESEARCH | 957 | 1% | 0% | 24 |
6 | JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM | 731 | 1% | 0% | 16 |
7 | RESTORATIVE NEUROLOGY AND NEUROSCIENCE | 661 | 0% | 1% | 7 |
8 | NEURAL REGENERATION RESEARCH | 536 | 1% | 0% | 10 |
9 | JOURNAL OF NEUROTRAUMA | 520 | 1% | 0% | 11 |
10 | NEUROLOGICAL RESEARCH | 461 | 1% | 0% | 10 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ERYTHROPOIETIN | 2769616 | 50% | 18% | 965 | Search ERYTHROPOIETIN | Search ERYTHROPOIETIN |
2 | CARBAMYLATED ERYTHROPOIETIN | 325426 | 1% | 86% | 24 | Search CARBAMYLATED+ERYTHROPOIETIN | Search CARBAMYLATED+ERYTHROPOIETIN |
3 | ERYTHROPOIETIN RECEPTOR | 300654 | 4% | 24% | 78 | Search ERYTHROPOIETIN+RECEPTOR | Search ERYTHROPOIETIN+RECEPTOR |
4 | EPO | 209104 | 4% | 19% | 69 | Search EPO | Search EPO |
5 | ASIALOERYTHROPOIETIN | 159513 | 1% | 92% | 11 | Search ASIALOERYTHROPOIETIN | Search ASIALOERYTHROPOIETIN |
6 | EPO RECEPTOR | 86228 | 1% | 42% | 13 | Search EPO+RECEPTOR | Search EPO+RECEPTOR |
7 | RHEPO | 71411 | 1% | 27% | 17 | Search RHEPO | Search RHEPO |
8 | ERYTHROPOIETIN EPO | 71150 | 1% | 19% | 24 | Search ERYTHROPOIETIN+EPO | Search ERYTHROPOIETIN+EPO |
9 | ARA290 | 65914 | 0% | 83% | 5 | Search ARA290 | Search ARA290 |
10 | CEPO | 65914 | 0% | 83% | 5 | Search CEPO | Search CEPO |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | VELLY, L , PELLEGRINI, L , GUILLET, B , BRUDER, N , PISANO, P , (2010) ERYTHROPOIETIN 2ND CEREBRAL PROTECTION AFTER ACUTE INJURIES: A DOUBLE-EDGED SWORD?.PHARMACOLOGY & THERAPEUTICS. VOL. 128. ISSUE 3. P. 445 -459 | 167 | 77% | 47 |
2 | ARCASOY, MO , (2008) THE NON-HAEMATOPOIETIC BIOLOGICAL EFFECTS OF ERYTHROPOIETIN.BRITISH JOURNAL OF HAEMATOLOGY. VOL. 141. ISSUE 1. P. 14 -31 | 136 | 72% | 203 |
3 | BRINES, M , CERAMI, A , (2008) ERYTHROPOIETIN-MEDIATED TISSUE PROTECTION: REDUCING COLLATERAL DAMAGE FROM THE PRIMARY INJURY RESPONSE.JOURNAL OF INTERNAL MEDICINE. VOL. 264. ISSUE 5. P. 405 -432 | 135 | 71% | 172 |
4 | SIREN, AL , FASSHAUER, T , BARTELS, C , EHRENREICH, H , (2009) THERAPEUTIC POTENTIAL OF ERYTHROPOIETIN AND ITS STRUCTURAL OR FUNCTIONAL VARIANTS IN THE NERVOUS SYSTEM.NEUROTHERAPEUTICS. VOL. 6. ISSUE 1. P. 108-127 | 99 | 76% | 105 |
5 | LIU, XB , WANG, JA , YU, SP , KEOGH, CL , WEI, L , (2008) THERAPEUTIC STRATEGY OF ERYTHROPOIETIN IN NEUROLOGICAL DISORDERS.CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. VOL. 7. ISSUE 3. P. 227-234 | 109 | 75% | 21 |
6 | GENC, S , KOROGLU, TF , GENC, K , (2004) ERYTHROPOIETIN AND THE NERVOUS SYSTEM.BRAIN RESEARCH. VOL. 1000. ISSUE 1-2. P. 19-31 | 92 | 88% | 95 |
7 | NOGUCHI, CT , ASAVARITIKRAI, P , TENG, R , JIA, Y , (2007) ROLE OF ERYTHROPOIETIN IN THE BRAIN.CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. VOL. 64. ISSUE 2. P. 159-171 | 90 | 78% | 104 |
8 | RANGARAJAN, V , JUUL, SE , (2014) ERYTHROPOIETIN: EMERGING ROLE OF ERYTHROPOIETIN IN NEONATAL NEUROPROTECTION.PEDIATRIC NEUROLOGY. VOL. 51. ISSUE 4. P. 481 -488 | 77 | 82% | 11 |
9 | KUMRAL, A , TUZUN, F , ONER, MG , GENC, S , DUMAN, N , OUML;ZKAN, H , (2011) ERYTHROPOIETIN IN NEONATAL BRAIN PROTECTION: THE PAST, THE PRESENT AND THE FUTURE.BRAIN & DEVELOPMENT. VOL. 33. ISSUE 8. P. 632 -643 | 90 | 74% | 22 |
10 | MAIESE, K , CHONG, ZZ , SHANG, YC , WANG, SH , (2012) ERYTHROPOIETIN: NEW DIRECTIONS FOR THE NERVOUS SYSTEM.INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. VOL. 13. ISSUE 9. P. 11102-11129 | 123 | 52% | 17 |
Classes with closest relation at Level 1 |